How an East Bay cancer fighter — once kicked to the curb by Big Pharma — picked up its 4th drug approval
January 15, 2019 at 09:32 AM EST
The Alameda company now has won FDA approval of the drug in thyroid, kidney and liver cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|